ArticleAntimicrobial agents and chemotherapy2009

The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100.

Tsutomu Murakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.